Henry Schein, Inc. (Nasdaq: HSIC), a Melville, NY-based provider of health care solutions, acquired Condor Dental Research Company SA (Condor Dental), a Vouvry, Switzerland-based dental distribution company.
Henry Schein acquired 100% of Condor Dental from MCCB II Holding, owned by Christèle Herreman. This transaction is expected to be neutral to Henry Schein’s 2022 diluted earnings per share and to be accretive thereafter. The amount of the deal was not disclosed
Since 2004, Henry Schein has served the Swiss dental implant market through Camlog Biotechnologies GmbH, a Basel-based division of Henry Schein, Inc., a member of the Company’s Global Oral Reconstruction Group, and a global leader in dental implants, biomaterials, and oral reconstruction. With the acquisition, Henry Schein will now expand its entry into the Swiss market for its dental distribution business. With the transaction closed, Condor Dental joins Henry Schein’s International Distribution Group, and the business will continue to be led by Yves Mailliard, Condor’s Chief Operating Officer.
Established in 1978, Condor Dental had approximately $18 million in sales for 2021, the majority of which were from dental consumable merchandise, with further revenue from the design and customization of dental practices and dental laboratory installations.
Led by CEO Stanley M. Bergman, Henry Schein is a solutions company for health care professionals powered by a network of people and technology. With nearly 22,000 Team Schein Members worldwide, the company’s network of advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work efficiently so they can provide quality. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
FinSMEs
11/07/2022